X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (88) 88
male (64) 64
female (59) 59
gastroenterology & hepatology (57) 57
middle aged (51) 51
index medicus (46) 46
aged (39) 39
hepatocellular carcinoma (36) 36
adult (33) 33
interferon (29) 29
hepatitis c (27) 27
hepatitis c, chronic - drug therapy (27) 27
hepatitis c virus (26) 26
hepatitis (24) 24
antiviral agents - therapeutic use (22) 22
genotype (20) 20
risk factors (20) 20
health aspects (19) 19
mutation (19) 19
chemistry (18) 18
hepatology (18) 18
heterocyclic compounds (18) 18
human necessities (18) 18
hygiene (18) 18
liver (18) 18
liver cancer (18) 18
medical or veterinary science (18) 18
metallurgy (18) 18
organic chemistry (18) 18
performing operations (18) 18
physical or chemical processes or apparatus in general (18) 18
preparations for medical, dental, or toilet purposes (18) 18
separation (18) 18
transporting (18) 18
infection (17) 17
treatment outcome (17) 17
molecular sequence data (16) 16
ribavirin (16) 16
specific therapeutic activity of chemical compounds ormedicinal preparations (16) 16
virology (15) 15
air-conditioning, air-humidification, ventilation, use of aircurrents for screening (14) 14
analysis (14) 14
blasting (14) 14
cirrhosis (14) 14
heating (14) 14
hepacivirus - genetics (14) 14
interferon-alpha - therapeutic use (14) 14
lighting (14) 14
mechanical engineering (14) 14
ranges (14) 14
ribavirin - therapeutic use (14) 14
ventilating (14) 14
weapons (14) 14
genetic aspects (13) 13
heat exchange in general (13) 13
heat-exchange apparatus, not provided for in another subclass,in which the heat-exchange media do not come into direct contact (13) 13
hepatitis b virus - genetics (13) 13
hepatoma (13) 13
therapy (13) 13
acyclic or carbocyclic compounds (12) 12
animals (12) 12
biological response modifiers (12) 12
care and treatment (12) 12
digestive system diseases (12) 12
expression (12) 12
gastroenterology (12) 12
hepatitis c, chronic - complications (12) 12
chronic hepatitis c (11) 11
drug therapy, combination (11) 11
gastroenterology and hepatology (11) 11
genotypes (11) 11
hepacivirus - drug effects (11) 11
hepatitis b (11) 11
japan (11) 11
virus diseases (11) 11
amino acid sequence (10) 10
cancer (10) 10
fibrosis (10) 10
hepatitis b virus (10) 10
oncology (10) 10
patients (10) 10
prognosis (10) 10
radiofrequency ablation (10) 10
base sequence (9) 9
colorectal surgery (9) 9
interferons - therapeutic use (9) 9
liver neoplasms - pathology (9) 9
medical research (9) 9
medicine & public health (9) 9
multidisciplinary sciences (9) 9
multivariate analysis (9) 9
polymorphism, single nucleotide (9) 9
replication (9) 9
retrospective studies (9) 9
rna (9) 9
virus (9) 9
alpha-fetoproteins - metabolism (8) 8
carcinoma, hepatocellular - virology (8) 8
liver neoplasms - virology (8) 8
medicine, experimental (8) 8
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (291) 291
Japanese (28) 28
French (12) 12
German (12) 12
Chinese (2) 2
Korean (2) 2
Spanish (2) 2
Norwegian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Gastroenterology, ISSN 0944-1174, 5/2016, Volume 51, Issue 5, pp. 473 - 486
Journal Article
Journal of Gastroenterology, ISSN 0944-1174, 6/2018, Volume 53, Issue 6, pp. 780 - 786
Journal Article
Nihon Naika Gakkai Zasshi, ISSN 0021-5384, 07/2017, Volume 106, Issue 7, pp. 1481 - 1488
Journal Article
Rinsho byori. The Japanese journal of clinical pathology, ISSN 0047-1860, 07/2016, Volume 64, Issue 7, p. 780
Hepatitis C virus (HCV) infection is a common cause of hepatocellular carcinoma (HCC), which is the third most common cause of cancer mortality worldwide.... 
Hepatitis C - drug therapy | Antiviral Agents - therapeutic use | Genomics | Humans | Risk Factors | Hepacivirus - genetics | Genotype
Journal Article
SCIENTIFIC REPORTS, ISSN 2045-2322, 04/2019, Volume 9, Issue 1, pp. 5722 - 9
Resistance-associated substitutions (RASs) of hepatitis C virus (HCV) in the NS5A region impair the efficacy of NS5A inhibitors. In this study, we evaluated... 
GENOTYPE 1 | VELPATASVIR | POLYMORPHISMS | EFFICACY | MULTIDISCIPLINARY SCIENCES | DACLATASVIR | GLOBAL EPIDEMIOLOGY | INHIBITOR | ANTIVIRAL DRUGS | HCV INFECTION | NS3 | Disease resistance | Hepatitis | Antigens | Clonal deletion | Infectivity | Viruses | Replication | Interferon | Hepatitis C | Patients | Ribavirin | Genotypes
Journal Article
Journal of Gastroenterology and Hepatology, ISSN 0815-9319, 01/2016, Volume 31, Issue 1, pp. 12 - 13
Journal Article
Scientific Reports, ISSN 2045-2322, 07/2016, Volume 6, Issue 1, p. 29358
Journal Article
Nihon rinsho. Japanese journal of clinical medicine, ISSN 0047-1852, 02/2015, Volume 73, Issue 2, pp. 292 - 298
Journal Article
Nihon rinsho. Japanese journal of clinical medicine, ISSN 0047-1852, 02/2015, Volume 73, Issue 2, p. 292
The prevalence of older patients has been increasing in Japan, and this is an impending problem in other countries where viral spread has occurred more... 
Liver Neoplasms - prevention & control | Age Factors | Humans | Middle Aged | Adult | Aged | Hepatitis C, Chronic - drug therapy
Journal Article
Journal of Medical Virology, ISSN 0146-6615, 07/2017, Volume 89, Issue 7, pp. 1241 - 1247
Single nucleotide polymorphisms (SNPs) within or near interferon lambda 4 (IFNL4) gene located upstream of IFNL3 are associated with response to anti‐HCV... 
hepatitis C virus | genetic variation | innate immunity | interferon | gene expression | VIRUS | INTERLEUKIN 28B | RIBAVIRIN | LAMBDA 4 | ANTIVIRAL RESPONSE | IL28B | VIROLOGY | GENOTYPE 1 INFECTION | VIRAL CLEARANCE | GENOME-WIDE ASSOCIATION | Liver - virology | Ubiquitins - genetics | Humans | Middle Aged | Drug Resistance, Viral | Hepacivirus - genetics | Male | Interferons - therapeutic use | Interleukins - metabolism | Interleukins - genetics | Liver - immunology | Liver - drug effects | Adult | Female | Cytokines - genetics | Suppressor of Cytokine Signaling 1 Protein - genetics | Ribavirin - therapeutic use | Gene Expression Regulation | Interferon-alpha - therapeutic use | Genotype | Hepatitis C, Chronic - drug therapy | Ribavirin - adverse effects | Hepatitis C, Chronic - immunology | Aged | Polymorphism, Single Nucleotide | Hepatitis C, Chronic - genetics | Myxovirus Resistance Proteins - genetics | RNA, Messenger | Care and treatment | RNA | Genes | Genetic research | Interferon | Single nucleotide polymorphisms | Hepatitis C | Biological response modifiers | Hepatitis C virus | Gene expression | Therapy | Myxovirus resistance proteins | Liver | Linkage disequilibrium | Innate immunity | Infections | Single-nucleotide polymorphism | Immunity | Patients | Ribavirin | Hepatitis | Polyethylene glycol | Genotypes
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2017, Volume 67, Issue 5, pp. 933 - 939
Journal Article